FindTrial
Sign In

Pharmacokinetic study of 3,4-diaminopyridine in healthy Japanese volunteers.

Pharmacokinetic study of 3,4-diaminopyridine in healthy Japanese volunteers. - Pharmacokinetics of 3,4-DAP in Japanese volunteers.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000003431
Enrollment
5
Registered
2010-04-01
Start date
2010-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy volunteers

Interventions

Oral administration of 3,4-diaminopyridine

Sponsors

Iou National Hospital, NHO
Lead Sponsor
Kanazawa University Institute of Medical, Pharmaceutical and Health Sciences Faculty of Pharmacy
Collaborator

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: Get written informed consent.

Exclusion criteria

Exclusion criteria: Have results of blood test more than twice as high as normal levels. Take any drugs within a week of this study.

Design outcomes

Primary

MeasureTime frame
Blood concentration of 3,4-diaminopyridine—

Countries

Japan

Contacts

Public ContactNatsuko Ishida

Iou National Hospital, NHO Department of Pharmacy

natsukoi@iou.hosp.go.jp076-258-1180

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026